The role of inositol 1,4,5-trisphosphate receptors in Ca2+ signalling and the generation of arrhythmias in rat atrial myocytes

被引:187
作者
Mackenzie, L
Bootman, MD [1 ]
Laine, M
Berridge, MJ
Thuring, J
Holmes, A
Li, WH
Lipp, P
机构
[1] Babraham Inst, Mol Signalling Lab, Cambridge CB2 4AT, England
[2] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[3] Univ Texas, SW Med Ctr, Dept Cell Biol & Neurosci, Dallas, TX 75390 USA
[4] Univ Helsinki, Dept Med, Div Cardiol, Helsinki, Finland
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2002年 / 541卷 / 02期
关键词
D O I
10.1113/jphysiol.2001.013411
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Various cardio-active stimuli, including endothelin-1 (ET-1), exhibit potent arrhythmogenicity, but the underlying cellular mechanisms of their actions are largely unclear. We used isolated rat atrial myocytes and related changes in their subcellular Ca2+ signalling to the ability of various stimuli to induce diastolic, premature extra Ca2+ transients (ECTs). For this, we recorded global and spatially resolved Ca2+ signals in indo-1-and fluo-4-loaded atrial myocytes during electrical pacing. ET-1 exhibited a higher arrhythmogenicity (arrhythmogenic index; ratio of number of ECTs over fold-increase in Ca2+ response, 8.60; n = 8 cells) when compared with concentrations of cardiac glycosides (arrhythmogenic index, 4.10; n = 8 cells) or the beta-adrenergic agonist isoproterenol (arrhythmogenic index, 0.11; n = 6 cells) that gave similar increases in the global Ca2+ responses. Seventy-five percent of the ET-1-induced arrhythmogenic Ca2+ transients were accompanied by premature action potentials, while for digoxin this proportion was 25 %. The beta-adrenergic agonist failed to elicit a significant number of ECTs. Direct activation of inositol 1,4,5-trisphosphate (InsP(3)) receptors with a membrane-permeable InsP, ester (InsP(3) BM) mimicked the effect of ET-1 (arrhytbmogenic index, 14.70; n = 6 cells). Inhibition of InsP(3) receptors using 2 muM 2-amino-ethoxydiplienyl borate, which did not display any effects on Ca2+ signalling under control conditions, specifically suppressed the arrhythmogenic action of ET-1 and InsP(3)BM. Immunocytochemistry indicated a co-localisation of peripheral, junctional ryanodine receptors with InsP(3)Rs. Thus, the pronounced arrhythmogenic potency of ET-1 is due to the spatially specific recruitment of Ca2+ sparks by subsarcolemmal InsP(3)Rs. Summation of such sparks efficiently generates delayed afterdepolarisations that trigger premature action potentials. We conclude that the particular spatial profile of cellular Ca2+ signals is a major, previously unrecognised, determinant for arrhythmogenic potency and that the InsP(3) signalling cassette might therefore be a promising new target for understanding and managing atrial arrhythmia.
引用
收藏
页码:395 / 409
页数:15
相关论文
共 32 条
[1]   CELLULAR-ORIGINS OF THE TRANSIENT INWARD CURRENT IN CARDIAC MYOCYTES - ROLE OF FLUCTUATIONS AND WAVES OF ELEVATED INTRACELLULAR CALCIUM [J].
BERLIN, JR ;
CANNELL, MB ;
LEDERER, WJ .
CIRCULATION RESEARCH, 1989, 65 (01) :115-126
[2]   The versatility and universality of calcium signalling [J].
Berridge, MJ ;
Lipp, P ;
Bootman, MD .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) :11-21
[3]   Role of the phospholipase C-inositol 1,4,5-trisphosphate pathway in calcium release-activated calcium current and capacitative calcium entry [J].
Broad, LM ;
Braun, FJ ;
Lievremont, JP ;
Bird, GSJ ;
Kurosaki, T ;
Putney, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :15945-15952
[4]   EXCITATION-CONTRACTION COUPLING IN MAMMALIAN CARDIAC-CELLS [J].
CALLEWAERT, G .
CARDIOVASCULAR RESEARCH, 1992, 26 (10) :923-932
[5]   SUPPRESSION OF VENTRICULAR ARRHYTHMIAS DURING ISCHEMIA-REPERFUSION BY AGENTS INHIBITING INS(1,4,5)P-3 RELEASE [J].
DU, XJ ;
ANDERSON, KE ;
JACOBSEN, A ;
WOODCOCK, EA ;
DART, AM .
CIRCULATION, 1995, 91 (11) :2712-2716
[6]  
EZEKOWITZ MD, ANN INTERNAL MED, V13, P537
[7]   Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice - A major role for inositol 1,4,5-trisphosphate [J].
Felzen, B ;
Shilkrut, M ;
Less, H ;
Sarapov, I ;
Maor, G ;
Coleman, R ;
Robinson, RB ;
Berke, G ;
Binah, O .
CIRCULATION RESEARCH, 1998, 82 (04) :438-450
[8]  
FOZZARD HA, 1992, BASIC RES CARDIOL, V87, P105
[9]   DIFFERENTIAL REGULATION OF 2 TYPES OF INTRACELLULAR CALCIUM-RELEASE CHANNELS DURING END-STAGE HEART-FAILURE [J].
GO, LO ;
MOSCHELLA, MC ;
WATRAS, J ;
HANDA, KK ;
FYFE, BS ;
MARKS, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :888-894
[10]  
GOLFMAN LS, 1993, CAN J CARDIOL, V9, P635